The Effect of Transcutaneous Vagal Nerve Stimulation (tVNS) on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid Hemorrhage

NANot yet recruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

September 30, 2026

Primary Completion Date

September 30, 2027

Study Completion Date

September 30, 2028

Conditions
Aneurysmal Subarachnoid HemorrhageVasospasm, CerebralTranscutaneous Vagal Nerve Stimulation (tVNS)Endovascular Treatment
Interventions
DEVICE

Transcutaneous Vagal Nerve Stimulation

Participants will receive up to 4 sessions per day of up to 20-minute stimulation, over the next 10 days of their inpatient hospital stay, following endovascular treatment. Stimulation will be provided by the tVNS device through a small electrode placed around the ear that will send low intensity, pulsed, electrical pulses the vagus nerve.

Trial Locations (1)

35233

UAB Hospital, Birmingham

All Listed Sponsors
lead

Marshall Holland

OTHER